| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/10/2008 | WO2008010222A3 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders |
| 04/10/2008 | WO2007146070A3 Liposome-mediated native chemical ligation |
| 04/10/2008 | WO2007143311A3 Solid medicament dosage form consumption aid |
| 04/10/2008 | WO2007109523A3 Stabilized ophthalmic compositions comprising oxidatively unstable components |
| 04/10/2008 | WO2007107161A3 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 04/10/2008 | WO2007105071A3 Composition for cosmetic or pharmaceutical-dermatological use |
| 04/10/2008 | WO2007096382A3 Method for production of a transformed cell |
| 04/10/2008 | WO2007061752A3 Biocompatible latent emulsifiers |
| 04/10/2008 | US20080086016 lisdexamfetamine, lisdexamfetamine dimesylate and lisdexamfetamine hydrochloride; attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity |
| 04/10/2008 | US20080085994 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 04/10/2008 | US20080085940 High speed formation of a high quality, uniform pore array in a polymeric thin film using laser beams; passing light through the film, detecting and analyzing to determine if the pores meet size and shape criterion; aerosolizing a drug and carrier; inhaling |
| 04/10/2008 | US20080085929 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same |
| 04/10/2008 | US20080085862 Natriuretic peptide conjugate using carrier substance |
| 04/10/2008 | US20080085857 conjugate consisting essentially of a NK4 molecule and a polyethylene glycol group having a molecular weight of from about 20 to about 40 kDa. The invention also provides a composition in which the monoPEGylated conjugates comprise at least 90% of the total of pegylated NK4 molecules and unpegylated NK4 |
| 04/10/2008 | US20080085853 nuclear delivery construct comprises (i) protein H or a fragment or derivative thereof that is capable of being targeted to the nucleus of a eukaryotic cell; |
| 04/10/2008 | US20080085317 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions |
| 04/10/2008 | US20080085316 Crosslinked gelatin powder containing rehydration aid such as polyethylene glycol, polyvinylpyrrolidone, and dextran |
| 04/10/2008 | US20080085309 Treated starch having a degree of gelatinization of 30-60% dispersed in the tablet also containing a drug, and a saccharide; rapid disintegrability, solubility, and appropriate hardness without using special fillers, apparatus; high strength; saccharide mixture of low/high moldibility powder and paste |
| 04/10/2008 | US20080085291 Solid cosmetic and therapeutic compositions applicable to the human skin and gellable on contact with water |
| 04/10/2008 | US20080085272 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/10/2008 | CA2848238A1 Lipid containing formulations |
| 04/10/2008 | CA2665689A1 Glutathione preparation and method for production thereof |
| 04/10/2008 | CA2665356A1 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 04/10/2008 | CA2665105A1 Injectable depot composition and its' process of preparation |
| 04/10/2008 | CA2665101A1 Injectable depot composition and it's process of preparation |
| 04/10/2008 | CA2665037A1 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 04/10/2008 | CA2664641A1 Controlled release dosage form of tacrolimus |
| 04/10/2008 | CA2664637A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 04/10/2008 | CA2664341A1 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 04/10/2008 | CA2664242A1 Comb polymers and use thereof for the production of active or effective ingredient formulations |
| 04/10/2008 | CA2664158A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | CA2663817A1 Self-preserved aqueous pharmaceutical compositions |
| 04/09/2008 | EP1908511A1 Granule dispersion composition, process for producing the same, and granular material and medicine |
| 04/09/2008 | EP1908482A1 Stabilizer for protein preparation comprising meglumine and use thereof |
| 04/09/2008 | EP1908449A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
| 04/09/2008 | EP1907843A2 Uniformly conjugated serine hydrolases |
| 04/09/2008 | EP1907482A1 Hydrogen bonded hydrogels |
| 04/09/2008 | EP1907444A2 Polymeric micelles for drug delivery |
| 04/09/2008 | EP1907022A2 Compositions for topical enzymatic debridement |
| 04/09/2008 | EP1907011A2 Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes |
| 04/09/2008 | EP1907010A2 Peptides for use in the treatment of obesity |
| 04/09/2008 | EP1907009A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 04/09/2008 | EP1907008A2 Formulations for enhanced mucosal delivery of pyy |
| 04/09/2008 | EP1907007A2 Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease |
| 04/09/2008 | EP1907006A2 Prevention and treatment of ophthalmic complications of diabetes |
| 04/09/2008 | EP1906990A1 Anticoagulation agent and uses thereof |
| 04/09/2008 | EP1906976A2 Therapeutic polymers and methods of use |
| 04/09/2008 | EP1906971A2 Antiviral compounds |
| 04/09/2008 | EP1906945A2 Hcv inhibitors |
| 04/09/2008 | EP1906938A2 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 04/09/2008 | EP1906937A2 Novel dispersible tablet composition |
| 04/09/2008 | EP1906931A1 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof |
| 04/09/2008 | EP1906930A2 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/09/2008 | EP1906929A2 Biodegradable peptide sustained release compositions containing porogens |
| 04/09/2008 | EP1906924A1 Bone marrow-directing drug delivery materials and their applications |
| 04/09/2008 | EP1906922A2 Formulations for alteration of biophysical properties of mucosal lining |
| 04/09/2008 | EP1906921A1 Clear pharmaceutical aqueous microemulsion comprising propofuol and process for preparation |
| 04/09/2008 | EP1906915A1 Particles having hydrophobic material therein |
| 04/09/2008 | EP1906911A1 Particles comprising a releasable dopant therein |
| 04/09/2008 | EP1748770B1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 04/09/2008 | EP1553910B1 A capsule filling machine |
| 04/09/2008 | EP1476489B1 Hydrolytically degradable alkylene oxide based polymers |
| 04/09/2008 | EP1474171B1 Weight management system for obese animals |
| 04/09/2008 | EP1370247B1 Taste masked pharmaceutical compositions |
| 04/09/2008 | EP1360311B1 Membrane penetrating peptides and uses thereof |
| 04/09/2008 | EP1325060B1 Soybean-based thermoplastics as biomaterials |
| 04/09/2008 | EP1299348B1 Compounds and compositions for delivering active agents |
| 04/09/2008 | EP1276467B1 Guaifenesin sustained release formulation and tablets |
| 04/09/2008 | EP1135106B1 Sustained release matrix systems for highly soluble drugs |
| 04/09/2008 | EP1124551B1 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 04/09/2008 | EP0693924B2 Methods for (in vivo) delivery of biologics and compositions useful therefor |
| 04/09/2008 | CN201044823Y Medicine label for treating deficiency and excess heterogeneous type slow branch acupoint |
| 04/09/2008 | CN101160403A Molecules for transporting a compound across the blood-brain barrier |
| 04/09/2008 | CN101160354A Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| 04/09/2008 | CN101157752A Method for preparing temperature-sensitive three-segmented copolymer |
| 04/09/2008 | CN101157612A Organic acid menthol derivative and transdermal drug delivery preparation having the same |
| 04/09/2008 | CN101157600A Antineoplastic drug Combretastatin water-soluble derivative and method for making same |
| 04/09/2008 | CN101156952A DC cell targeted carrier, nanometer corpuscle and preparation method |
| 04/09/2008 | CN101156951A Method and composition for eliminating odors in ion exchange resins |
| 04/09/2008 | CN101156950A Method of preparing photo-dynamical medicine nanometer magnetic carrier |
| 04/09/2008 | CN101156929A Turmeric water-insoluble saponin liposome as well as its preparing method and application |
| 04/09/2008 | CN101156895A Medicine for curing headache and its preparing method |
| 04/09/2008 | CN101156886A A composition for regulating intestinal canal flora and improving hypoxiatolerance force as well as its preparation method |
| 04/09/2008 | CN101156870A A composition for improving growth development and help in improving anamnesis as well as its preparation method |
| 04/09/2008 | CN101156867A Tea polyphenol pellicle and method for making same |
| 04/09/2008 | CN101156864A A roxoithromycin and compound recipe preparation |
| 04/09/2008 | CN101156860A Use of mometasone furoate for treating airway passage and lung diseases |
| 04/09/2008 | CN101156859A Hydrochloric acid chlorine imipramine sublingual piece and method for making same |
| 04/09/2008 | CN101156856A Falacyclovir dispersion piece and its preparation method |
| 04/09/2008 | CN101156855A Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| 04/09/2008 | CN101156854A Method for preparing camptothecin medicine slow releasing microcapsule |
| 04/09/2008 | CN101156853A Hydrochloric acid glitazone dispersion piece and its preparation method |
| 04/09/2008 | CN101156852A Lansoprazole intestine solution capsule and its preparation method |
| 04/09/2008 | CN101156851A Nicardipine hydrochloride dispersion piece and method for making same |
| 04/09/2008 | CN101156849A An alepsin slow-releasing gel for promoting paradontal part reborn as well as preparation method and application |
| 04/09/2008 | CN101156846A A buccal pellicle for treating gingivitis and oral mucosa canker as well as its preparation method |
| 04/09/2008 | CN101156844A A microemulsion medicinal composition containing Docetaxel for treating knub and its preparation method |
| 04/09/2008 | CN101156838A Konjak glucomannan medicinal coating film and its preparation method |